Literature DB >> 27122485

Parenteral Vaccination Can Be an Effective Means of Inducing Protective Mucosal Responses.

John D Clements1, Lucy C Freytag2.   

Abstract

The current paradigm in vaccine development is that nonreplicating vaccines delivered parenterally fail to induce immune responses in mucosal tissues. However, both clinical and experimental data have challenged this concept, and numerous studies have shown that induction of mucosal immune responses after parenteral vaccination is not a rare occurrence and might, in fact, significantly contribute to the protection against mucosal infections afforded by parenteral vaccines. While the mechanisms underlying this phenomenon are not well understood, the realization that parenteral vaccination can be an effective means of inducing protective mucosal responses is paradigm-shifting and has potential to transform the way vaccines are designed and delivered.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27122485      PMCID: PMC4895008          DOI: 10.1128/CVI.00214-16

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  20 in total

1.  The induction of systemic and mucosal immune responses following the subcutaneous immunization of mature adult mice: characterization of the antibodies in mucosal secretions of animals immunized with antigen formulations containing a vitamin D3 adjuvant.

Authors:  E Y Enioutina; D Visic; Z A McGee; R A Daynes
Journal:  Vaccine       Date:  1999-08-06       Impact factor: 3.641

2.  A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.

Authors:  Michael A Egan; Siew Yen Chong; Michael Hagen; Shakuntala Megati; Eva B Schadeck; Priscilla Piacente; Ben-Jiang Ma; David C Montefiori; Barton F Haynes; Zimra R Israel; John H Eldridge; Herman F Staats
Journal:  Vaccine       Date:  2004-09-09       Impact factor: 3.641

3.  Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model.

Authors:  Chunmei Cheng; Sukumar Pal; Ilham Bettahi; Kristie L Oxford; Peter A Barry; Luis M de la Maza
Journal:  Vaccine       Date:  2011-03-04       Impact factor: 3.641

4.  Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women.

Authors:  B A Halperin; A Morris; D Mackinnon-Cameron; J Mutch; J M Langley; S A McNeil; D Macdougall; S A Halperin
Journal:  Clin Infect Dis       Date:  2011-09-26       Impact factor: 9.079

5.  Local antibody response to poliovaccine in the human female genital tract.

Authors:  P L Ogra; S S Ogra
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

6.  Anomalous observations on IPV and OPV vaccination.

Authors:  T J John
Journal:  Dev Biol (Basel)       Date:  2001

7.  The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model.

Authors:  Elizabeth B Norton; David L Bauer; William C Weldon; M Steven Oberste; Louise B Lawson; John D Clements
Journal:  Vaccine       Date:  2015-03-09       Impact factor: 3.641

8.  Enteric flora expands gut lamina propria CX3CR1+ dendritic cells supporting inflammatory immune responses under normal and inflammatory conditions.

Authors:  Jan Hendrik Niess; Guido Adler
Journal:  J Immunol       Date:  2010-01-20       Impact factor: 5.422

9.  Parenteral influenza vaccination induces a rapid systemic and local immune response.

Authors:  K A Brokstad; R J Cox; J Olofsson; R Jonsson; L R Haaheim
Journal:  J Infect Dis       Date:  1995-01       Impact factor: 5.226

10.  Transcutaneous immunization: a human vaccine delivery strategy using a patch.

Authors:  G M Glenn; D N Taylor; X Li; S Frankel; A Montemarano; C R Alving
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

View more
  29 in total

1.  New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes.

Authors:  Mario Amacker; Charli Smardon; Laura Mason; Jack Sorrell; Kirk Jeffery; Michael Adler; Farien Bhoelan; Olga Belova; Mark Spengler; Beena Punnamoottil; Markus Schwaller; Olivia Bonduelle; Behazine Combadière; Toon Stegmann; Andrew Naylor; Richard Johnson; Desmond Wong; Sylvain Fleury
Journal:  NPJ Vaccines       Date:  2020-05-18       Impact factor: 7.344

2.  Shigella Vaccine Development: Finding the Path of Least Resistance.

Authors:  Wilbur H Chen; Karen L Kotloff
Journal:  Clin Vaccine Immunol       Date:  2016-12-05

3.  Coexpression of respiratory syncytial virus (RSV) fusion (F) protein and attachment glycoprotein (G) in a vesicular stomatitis virus (VSV) vector system provides synergistic effects against RSV infection in a cotton rat model.

Authors:  Kelsey A Brakel; Basavaraj Binjawadagi; Kristen French-Kim; Mauria Watts; Olivia Harder; Yuanmei Ma; Jianrong Li; Stefan Niewiesk
Journal:  Vaccine       Date:  2021-10-23       Impact factor: 3.641

Review 4.  Diagnosis, Management, and Future Control of Cholera.

Authors:  Fahima Chowdhury; Allen G Ross; Md Taufiqul Islam; Nigel A J McMillan; Firdausi Qadri
Journal:  Clin Microbiol Rev       Date:  2022-06-21       Impact factor: 50.129

5.  Vaccine-induced time- and age-dependent mucosal immunity to gastrointestinal parasite infection.

Authors:  Wei Liu; Tom N McNeilly; Mairi Mitchell; Stewart T G Burgess; Alasdair J Nisbet; Jacqueline B Matthews; Simon A Babayan
Journal:  NPJ Vaccines       Date:  2022-07-07       Impact factor: 9.399

6.  Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate.

Authors:  Hyesuk Seo; Carolina Garcia; Xiaosai Ruan; Qiangde Duan; David A Sack; Weiping Zhang
Journal:  Infect Immun       Date:  2021-06-16       Impact factor: 3.441

7.  A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.

Authors:  Fabián E Díaz; Mariana Guerra-Maupome; Paiton O McDonald; Daniela Rivera-Pérez; Alexis M Kalergis; Jodi L McGill
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

Review 8.  The Rotavirus Vaccine Landscape, an Update.

Authors:  Roberto Cárcamo-Calvo; Carlos Muñoz; Javier Buesa; Jesús Rodríguez-Díaz; Roberto Gozalbo-Rovira
Journal:  Pathogens       Date:  2021-04-26

Review 9.  Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?

Authors:  Mattia Tiboni; Luca Casettari; Lisbeth Illum
Journal:  Int J Pharm       Date:  2021-05-06       Impact factor: 6.510

10.  Subcutaneous Immunization with Recombinant Lactococcus lactis Expressing F1S1 Fusion Protein Induces Systemic and Mucosal Immune Responses in BALB/C Mice.

Authors:  Ali Torkashvand; Fariborz Bahrami; Minoo Adib; Soheila Ajdary
Journal:  Rep Biochem Mol Biol       Date:  2019-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.